Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norito Takamura

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|August 19, 2008
Usefulness of competitive inhibitors of protein binding for improving the pharmacokinetics of 186Re-MAG3-conjugated bisphosphonate (186Re-MAG3-HBP), an agent for treatment of painful bone metastasesKazuma Ogawa, Takahiro Mukai, Keiichi Kawai, et al.
European Journal of Drug Metabolism and Pharmacokinetics|December 25, 2014
A novel injection strategy of flurbiprofen axetil by inhibiting protein binding with 6-methoxy-2-naphthylacetic acidKenji Ogata, Norito Takamura, Jin Tokunaga, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 11, 2005
Bucolome, a potent binding inhibitor for furosemide, alters the pharmacokinetics and diuretic effect of furosemide: potential for use of bucolome to restore diuretic response in nephrotic syndromeNorito Takamura, Toru Maruyama, Etsuo Chosa, et al.
Pharmaceutical Research|June 24, 2003
Effect of P-glycoprotein modulator, cyclosporin A, on the gastrointestinal excretion of irinotecan and its metabolite SN-38 in ratsKazuhiko Arimori, Noriaki Kuroki, Muneaki Hidaka, et al.
American Journal of Pharmaceutical Education|February 7, 2015
An advanced objective structured clinical examination using patient simulators to evaluate pharmacy students' skills in physical assessmentJin Tokunaga, Norito Takamura, Kenji Ogata, et al.
Nuclear Medicine and Biology|February 3, 2009
Serum protein binding displacement: theoretical analysis using a hypothetical radiopharmaceutical and experimental analysis with 123I-N-isopropyl-p-iodoamphetamineKeiichi Kawai, Ryuichi Nishii, Naoto Shikano, et al.
Biopharmaceutics & Drug Disposition|December 11, 2012
A diclofenac suppository-nabumetone combination therapy for arthritic pain relief and a monitoring method for the diclofenac binding capacity of HSA site II in rheumatoid arthritisNao Setoguchi, Norito Takamura, Ken-ichi Fujita, et al.
Biological & Pharmaceutical Bulletin|September 3, 2003
Inhibitory effects of citrus fruits on cytochrome P450 3A (CYP3A) activity in humansKen-Ichi Fujita, Muneaki Hidaka, Norito Takamura, et al.
Nuclear Medicine and Biology|January 15, 2013
Pharmacokinetic alteration of (99m)Tc-MAG3 using serum protein binding displacement methodKodai Nishi, Masato Kobayashi, Ryuichi Nishii, et al.
Biological & Pharmaceutical Bulletin|March 4, 2005
Inhibitory effects of amino-acid fluids on drug binding to site II of human serum albumin in vitroKeishi Yamasaki, Noriyuki Kuga, Norito Takamura, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
European Journal of Nuclear Medicine and Molecular Imaging|August 19, 2008
Usefulness of competitive inhibitors of protein binding for improving the pharmacokinetics of 186Re-MAG3-conjugated bisphosphonate (186Re-MAG3-HBP), an agent for treatment of painful bone metastasesKazuma Ogawa, Takahiro Mukai, Keiichi Kawai, et al.
European Journal of Drug Metabolism and Pharmacokinetics|December 25, 2014
A novel injection strategy of flurbiprofen axetil by inhibiting protein binding with 6-methoxy-2-naphthylacetic acidKenji Ogata, Norito Takamura, Jin Tokunaga, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 11, 2005
Bucolome, a potent binding inhibitor for furosemide, alters the pharmacokinetics and diuretic effect of furosemide: potential for use of bucolome to restore diuretic response in nephrotic syndromeNorito Takamura, Toru Maruyama, Etsuo Chosa, et al.
Pharmaceutical Research|June 24, 2003
Effect of P-glycoprotein modulator, cyclosporin A, on the gastrointestinal excretion of irinotecan and its metabolite SN-38 in ratsKazuhiko Arimori, Noriaki Kuroki, Muneaki Hidaka, et al.
American Journal of Pharmaceutical Education|February 7, 2015
An advanced objective structured clinical examination using patient simulators to evaluate pharmacy students' skills in physical assessmentJin Tokunaga, Norito Takamura, Kenji Ogata, et al.
Nuclear Medicine and Biology|February 3, 2009
Serum protein binding displacement: theoretical analysis using a hypothetical radiopharmaceutical and experimental analysis with 123I-N-isopropyl-p-iodoamphetamineKeiichi Kawai, Ryuichi Nishii, Naoto Shikano, et al.
Biopharmaceutics & Drug Disposition|December 11, 2012
A diclofenac suppository-nabumetone combination therapy for arthritic pain relief and a monitoring method for the diclofenac binding capacity of HSA site II in rheumatoid arthritisNao Setoguchi, Norito Takamura, Ken-ichi Fujita, et al.
Biological & Pharmaceutical Bulletin|September 3, 2003
Inhibitory effects of citrus fruits on cytochrome P450 3A (CYP3A) activity in humansKen-Ichi Fujita, Muneaki Hidaka, Norito Takamura, et al.
Nuclear Medicine and Biology|January 15, 2013
Pharmacokinetic alteration of (99m)Tc-MAG3 using serum protein binding displacement methodKodai Nishi, Masato Kobayashi, Ryuichi Nishii, et al.
Biological & Pharmaceutical Bulletin|March 4, 2005
Inhibitory effects of amino-acid fluids on drug binding to site II of human serum albumin in vitroKeishi Yamasaki, Noriyuki Kuga, Norito Takamura, et al.
Pageof 4